Primary Site >> Liver Cancer

Gene >> RASSF10

Journal: Genes Cancer. 2015 May;6(5-6):231-40.
Title: RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker.
Author: Jin, Yongshuai|Cao, Baoping|Zhang, Meiying|Zhan, Qimin|Herman, James G|Yu, Miao|Guo, Mingzhou
PMID: 26124922
Journal: Oncotarget. 2016 Jan 26;7(4):4279-97.
Title: RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
Author: Wang, Fei|Feng, Ying|Li, Peng|Wang, Kun|Feng, Liang|Liu, Yi-Fei|Huang, Hua|Guo, Yi-Bing|Mao, Qin-Sheng|Xue, Wan-Jiang
PMID: 26701853
Journal: Oncogenesis. 2016 Jun 27;5(6):e237.
Title: Ras-association domain family 10 acts as a novel tumor suppressor through modulating MMP2 in hepatocarcinoma.
Author: Liu, W|Wang, J|Wang, L|Qian, C|Qian, Y|Xuan, H|Zhuo, W|Li, X|Yu, J|Si, J
PMID: 27348267
Journal: Eur Rev Med Pharmacol Sci. 2017 Aug;21(16):3576-3580.
Title: Study on the relationship between the RASSF10 gene and the biological behavior of hepatocellular carcinoma cells.
Author: Xie, J|Chen, Y|Meng, F|Shu, T|Liu, Y|Zhang, L|Zhang, Z-X
PMID: 28925496